This is a working overview of Heptapeptide, written for readers who want more than a one-paragraph summary but less than a textbook.
Reviewed 2026-08-01. Anything still debated is marked as such rather than presented as settled.
Quality assessment of research-grade peptide rests mainly on reversed-phase high-performance liquid chromatography for purity and on mass spectrometry for identity confirmation. A single main peak above a stated threshold, commonly ninety-eight percent by peak area, is the usual release criterion applied by suppliers. Independent analyses commissioned by laboratories and consumer organisations have repeatedly reported discrepancies between label claims and measured content, including truncated sequences, residual trifluoroacetate, and lower-than-declared peptide mass. Those findings do not establish that every supplier is unreliable, but they indicate that purity figures printed on a vial are claims requiring verification rather than settled facts.
Regulatory treatment varies by jurisdiction and has changed over time. In several countries the peptide is handled as an unapproved prescription medicine, and import or sale for human use is restricted, while elsewhere it falls under poisons or controlled-substance schedules. Enforcement activity against online vendors has been reported in Australia, New Zealand, the United Kingdom and the United States. Scholarly writing discusses melanotan-2 chiefly as an experimental tool and as a case study in unregulated peptide supply, and its precise legal position in any given country should be checked against current national schedules.
Melanotan II is a synthetic cyclic heptapeptide analogue of alpha-melanocyte-stimulating hormone, a naturally occurring peptide involved in pigmentation signalling. Its structure substitutes a lactam bridge between side chains to increase stability relative to the native hormone. The compound is also known by the shorthand MT-II and by several non-proprietary synonyms used in research catalogues. It is not an approved therapeutic product in any major jurisdiction; material sold under this name is typically offered as a laboratory reagent rather than as a medicine.
Activity is attributed to agonism at melanocortin receptors, particularly MC1R and MC4R. Activation of MC1R on melanocytes increases melanin synthesis, which underlies the reported tanning effect. MC4R engagement in the central nervous system is linked to appetite suppression and to effects on sexual arousal reported in early clinical studies. Those studies were small and were not designed to establish efficacy or long-term safety. Receptor selectivity among the melanocortin subtypes is not absolute, which complicates attribution of any effect to a single pathway.
Regulatory treatment varies between countries. Several national medicines agencies have classified the peptide as unapproved, and customs authorities in some jurisdictions seize shipments on that basis. A few jurisdictions channel supply through prescription-only frameworks that do not list the substance by name. Because the material circulates mainly through online vendors, composition and purity are rarely verified before sale. Surveys of unapproved peptide products have reported labels that did not match measured content in a substantial fraction of samples.
| Property | Value | Notes |
|---|---|---|
| Physical form | Lyophilised powder | Reconstitution is required before use in most assays |
| Solubility class | Freely soluble in water and acetonitrile; sparingly soluble in nonpolar solvents | Aqueous solutions may benefit from slight acidification |
| Typical storage temperature | -20 °C or lower, desiccated and protected from light | Short-term transport at 2-8 °C is common practice |
| Primary degradation routes | Oxidation, hydrolysis, aggregation | Tryptophan and histidine residues are the main oxidation targets |
| Quality marker | Chromatographic purity by peak area | Does not capture counter-ion content or residual solvents |
Lyophilized peptide powder is generally stored frozen, protected from light and moisture. Tryptophan residues are susceptible to oxidation, and the lactam bridge can hydrolyze under strongly acidic or basic conditions. Solutions prepared for laboratory work degrade faster than dry powder, and repeated freeze-thaw cycles accelerate loss. Common practice is to aliquot solutions before freezing and to avoid alkaline buffers. Reported stability windows vary with concentration, buffer, and temperature, so exact shelf lives are method-specific rather than universal.
Regulatory status differs by country, and in many places supplying the compound for human consumption is unlawful. Vendors frequently label material as intended for research use only, a designation that shifts stated purpose but does not create a legal pathway for personal use. Certificates of analysis accompanying such products vary widely in detail and provenance. Third-party testing exists but is voluntary, and results are rarely linked to a specific lot in a publicly verifiable way.
Identity testing for a synthetic peptide relies on several complementary methods. Reversed-phase high-performance liquid chromatography separates the target from related impurities and reports purity as a percentage of total peak area. Mass spectrometry confirms molecular mass and can reveal deletions or truncations. Amino acid analysis and peptide mapping provide sequence-level confirmation, while counter-ion content and residual solvents are measured separately. A purity figure alone does not establish identity, so a complete dataset combines chromatographic and spectrometric evidence.
Outside regulated medicine, melanotan II circulates through online vendors as a research chemical, often marketed for tanning. Products sold this way vary widely in purity, concentration, and labeling accuracy, and independent testing has documented discrepancies. Published reports describe both pigment effects and adverse reactions, including nausea, flushing, and darkening of existing moles. Long-term safety data are sparse, and no large controlled trial has established a risk profile. Questions about cumulative effects on melanocytes remain unresolved in the literature.
Melanotan II is a synthetic peptide analog modeled on alpha-melanocyte-stimulating hormone, a naturally occurring signaling peptide involved in pigmentation. Its structure is a cyclic heptapeptide containing two non-natural substitutions, norleucine at position four and D-phenylalanine at position seven. These modifications resist enzymatic breakdown and extend the molecule's activity relative to the native hormone. The compound binds melanocortin receptors and is studied mainly as a pharmacological tool rather than a therapeutic product. It has never received approval as a medicine in any major jurisdiction.
The compound was developed in the late 1980s and 1990s by academic researchers investigating photoprotection. The rationale held that stimulating melanin production might reduce ultraviolet damage to skin and lower skin cancer risk. Early work examined receptor binding, pigment response, and short-term tolerability in small studies. That program did not produce an approved drug, and formal development stalled after early-phase trials. Whether induced pigmentation confers meaningful photoprotection remains an open question.
Guiry, Michael; Guiry, Wendy. "AlgaeBase". – a database of all algal names including images, nomenclature, taxonomy, distribution, bibliography, uses, extracts "Algae – Cell Centered Database". CCDb.UCSD.edu. San Diego: University of California. Anderson, Don; Keafer, Bruce; Kleindinst, Judy; Shaughnessy, Katie; Joyce, Katherine; Fino, Danielle; Shepherd, Adam (2007). "Harmful Algae". US National Office for Harmful Algal Blooms. Archived from the original on 5 December 2008. Retrieved 19 December 2008. "About Algae". NMH.ac.uk. Natural History Museum, United Kingdom.
There was concern about the possibility of arsenic from embalmed bodies contaminating ground water supplies, as well as legal concerns that people suspected of murder by arsenic poisoning might claim that levels of poison in the deceased's body were the result of post-mortem embalming, not homicide. In 1855, the Russian chemist Alexander Michailowitsch Butlerow discovered formaldehyde, the preservative properties of which were soon noted, and it became the foundation for modern methods of embalming. Dr Frederic Ruysch was the first to have used the arterial injection method for embalming. His work of embalming was so nearly perfect that people thought the dead body was actually alive; however, he only used it to prepare specimens for his anatomical work.
International Chemical Safety Card 0275 (gas) International Chemical Safety Card 0695 (solution) NIOSH Pocket Guide to Chemical Hazards. "#0293". National Institute for Occupational Safety and Health (NIOSH). Entry for "Formaldehyde" on the Australian National Pollutant Inventory Formaldehyde from ChemSub Online Prevention guide—Formaldehyde in the Workplace (PDF) from the IRSST Formaldehyde from the National Institute for Occupational Safety and Health IPCS Health and Safety Guide 57: Formaldehyde IPCS Environmental Health Criteria 89: Formaldehyde SIDS Initial Assessment Report for Formaldehyde from the Organisation for Economic Co-operation and Development (OECD) Formaldehyde in the Pesticide Properties DataBase (PPDB)
Sources: en.wikipedia.org
Sam Camfield. Design Manager, South Western Railway. For services to the State Funeral of Her Majesty Queen Elizabeth II. William Wright Glover Campbell. Captain, 1st Stewarton Boys' Brigade. For services to the community in Stewarton, East Ayrshire. Bronwin Mary Carter. Paralympic Coach. For services to Sport. Christopher Charles Cassidy. Watchkeeper, Cabinet Office. For services to Civil Contingencies and to St John Ambulance. Ann Chapman. For services to the community in Radcliffe, Metropolitan Borough of Bury. Stephen Charnock. For services to the community in Newark, Nottinghamshire. Ian Raymond Clark. For services to the community in High Wycombe, Buckinghamshire. Roy Michael Claxton. Founder, Parkinson's Scottish Table Tennis Association. For services to People with Parkinson's Disease. Peter Stewart Clemson. Founder and Chair, Little Theatre Company. For services to the Performing Arts and to the community in Burton-on-Trent, Staffordshire. Judith Mary Climer. Founder, Michael Climer Legacy Fund. For services to the community in Caerphilly. Isobel Jennifer Clink. For services to Golf. Joy Henrietta Mary Coalter. Lately Building and Cleaning Supervisor, Brookeborough Primary School, County Fermanagh. For services to Education. Robert Coburn. Scottish Area Vice Chair, Royal Naval Association and Poppy Appeal Convenor. For voluntary service to Veterans and to the community in Inverness-shire (to be dated 27th November 2023). Dr Shara Cohen. Chief Executive Officer, Honnao Ltd. For voluntary services to Women in STEM and to Cancer Patients and their Families.
== ADLM Members == ADLM's approximately 8,000 members come from all areas of lab medicine—clinical and research laboratories, diagnostic companies, government agencies, original equipment manufacturers, and more. Collectively they develop and run lab tests and lab instruments used throughout healthcare. They also manage labs, conduct research involving biomarkers, and promote accurate diagnostic testing. ADLM represents the diverse interests of a global lab community: its members come from 110 countries and hold the spectrum of lab-related professional degrees, certifications, and credentials.
== In popular culture == In the third chapter of the book Ozempic, la révolution de l'obésité ̶ L’enquête titled A race for patents and Nobel Prizes devoted to Svetlana Mojsov the author Fabrice Delaye summerizes: “In 1982, the identification in animals of the slimming molecule GLP-1 triggered a fierce competition between Danish and American researchers to find it in humans. The race ended in success—but with one casualty: Svetlana Mojsov, a biochemist of Macedonian origin exiled in New York. She was the first to synthesize the molecule that is effective in the human body.” The second chapter, The Discovery—A Murky Area, of the book Off the Scales by Aimee Donnellan is devoted to the fundamental contribution of Svetlana Mojsov to the discovery of GLP-1, the unfair treatment by her collaborators at the Massachusetts General Hospital in Boston and her long plight to be recognized and included in the patents.
=== Threshold intake levels for adverse effects === Adverse health and social effects associated with kava consumption—such as skin rashes, increased body mass index (BMI), elevated gamma-glutamyl transferase (GGT) enzyme levels, and higher lymphocyte counts—may begin to appear at intake levels of approximately 240 to 440 grams of kava powder per week, corresponding to 3,500 to 6,440 mg of kavalactones per day. One shell of kava contains an average of 250 mg kavalactones. Published and anecdotal evidence further indicates that recreational consumption of kava beverages can often exceed these levels, surpassing the kavalactone doses used in clinical settings for the treatment of anxiety, which are aqueous extracts containing 140–250 mg, taken once per day over six weeks, have demonstrated no significant toxicity.
Sources: en.wikipedia.org
=== Industry sectors === Singapore is the world's third-largest foreign exchange centre, sixth-largest financial centre, second-largest casino gambling market, third-largest oil-refining and trading centre, largest oil-rig producer and hub for ship repair services, and largest logistics hub. The economy is diversified, with its top contributors being financial services, manufacturing, and oil-refining. Its main exports are refined petroleum, integrated circuits, and computers, which constituted 27% of the country's GDP in 2010. Other significant sectors include electronics, chemicals, mechanical engineering, and biomedical sciences. Singapore was ranked 5th in the Global Innovation Index in 2025. In 2019, there were more than 60 semiconductor companies in Singapore, which together constituted 11% of the global market share. The semiconductor industry alone contributes around 7% of Singapore's GDP. Singapore's largest companies are in the telecommunications, banking, transportation, and manufacturing sectors, many of which started as state-run statutory corporations and have since been publicly listed on the Singapore Exchange. Such companies include Singapore Telecommunications (Singtel), Singapore Technologies Engineering, Keppel Corporation, Oversea-Chinese Banking Corporation (OCBC), Development Bank of Singapore (DBS), and United Overseas Bank (UOB). In 2011, after the 2008 financial crisis, OCBC, DBS and UOB were ranked by Bloomberg Businessweek as the world's first, fifth, and sixth strongest banks in the world, respectively.
The muscular part of the uvula (Latin: musculus uvulae) shortens and broadens the uvula. This changes the contour of the posterior part of the soft palate. This change in contour allows the soft palate to adapt closely to the posterior pharyngeal wall to help close the nasopharynx during swallowing. Its muscles are controlled by the pharyngeal branch of the vagus nerve.
=== Post-synthetic modification === Although the three-dimensional structure and internal environment of the pores can be in theory controlled through proper selection of nodes and organic linking groups, the direct synthesis of such materials with the desired functionalities can be difficult due to the high sensitivity of MOF systems. Thermal and chemical sensitivity, as well as high reactivity of reaction materials, can make forming desired products challenging to achieve. The exchange of guest molecules and counter-ions and the removal of solvents allow for some additional functionality but are still limited to the integral parts of the framework. The post-synthetic exchange of organic linkers and metal ions is an expanding area of the field and opens up possibilities for more complex structures, increased functionality, and greater system control.
== Lewis acid strength in non-aqueous solutions == Lewis acids have been classified in the ECW model and it has been shown that there is no one order of acid strengths. The relative acceptor strength of Lewis acids toward a series of bases, versus other Lewis acids, can be illustrated by C-B plots. It has been shown that to define the order of Lewis acid strength at least two properties must be considered. For Pearson's qualitative HSAB theory the two properties are hardness and strength while for Drago's quantitative ECW model the two properties are electrostatic and covalent.
. The mechanics of contacting rough surfaces are discussed in terms of normal contact mechanics and static frictional interactions. Natural and engineering surfaces typically exhibit roughness features, known as asperities, across a broad range of length scales down to the molecular level, with surface structures exhibiting self affinity, also known as surface fractality. It is recognized that the self affine structure of surfaces is the origin of the linear scaling of true contact area with applied pressure. Assuming a model of shearing welded contacts in tribological interactions, this ubiquitously observed linearity between contact area and pressure can also be considered the origin of the linearity of the relationship between static friction and applied normal force. In contact between a "random rough" surface and an elastic half-space, the true contact area is related to the normal force
Sources: en.wikipedia.org
Solutions are best kept cold, protected from light, and buffered to a pH that limits hydrolysis. Dividing a stock into single-use aliquots avoids repeated freeze-thaw cycles, which measurably reduce the intact parent peak over time.
Reversed-phase chromatography establishes a purity profile, while electrospray or matrix-assisted laser desorption mass spectrometry confirms that the observed mass matches the expected sequence. Together they support, but do not fully prove, identity and purity.
Reviews generally characterise it as thin, dominated by small and often uncontrolled studies. Several authors explicitly note that findings on pigmentation, appetite and sexual function have not been confirmed in adequately powered controlled trials.
No. No major regulatory agency has granted a marketing authorisation for melanotan II as a medicine. Products sold under this name are generally presented as laboratory reagents and are not subject to the batch-release testing applied to approved drugs.